(Reuters) - U.S. health regulators on Tuesday said they approved OraSure Technologies Inc's in-home test for HIV, making it the first over-the-counter, self-administered test for the virus that causes AIDS. The Food and Drug Administration gave its green light to the OraQuick In-Home HIV Test, which within 20 to 40 minutes provides results from an oral fluid sample taken by swabbing the upper and lower gums inside the mouth. Shares of the company, which were halted pending the FDA announcement, closed up 5.2 percent at $12.10 on Nasdaq. The company said the test -- already approved for use by trained technicians -- will be available starting in October at more than 30,000 retailers...

Related "OraSure Technologies, Inc." Articles

(Reuters) - U.S. health regulators on Tuesday said they approved OraSure Technologies Inc's in-home test for HIV, making it the first over-the-counter, self-administered test for the virus that causes AIDS. The Food and Drug Administration gave its green...